Finepoint Capital LP
CIK 1608126
13F filing for Q2 2026・No. 1,339
- Holdings
- US$2.8B
- Quarter change
- +US$846.4M
- Entries
- 9
- Net bought (estimate)
- +US$82.33M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 0
- Sold out 0
- Cut 0
- Added 2
- Corporate actions 0
- Unchanged 4
Largest holdings
6 stocks worth US$461.03M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| QXOQXO INCCOM NEW | Added | 18,113,850 | US$313.01M | 67.89% |
| RXO INCCOMMON STOCK | AddedSplit 1:2 | 5,355,445 | US$147.76M | 32.05% |
| ALEANNA INC*W EXP 12/13/202 | Unchanged | 490,000 | US$147K | 0.03% |
| ALEANNA INCCOM CL A | Unchanged | 27,717 | US$80.38K | 0.02% |
| MONEYHERO LIMITED*W EXP 09/13/202 | Unchanged | 895,000 | US$36.96K | 0.01% |
| CALIDI BIOTHERAPEUTICS INCCOM | Unchanged | 1,042 | US$177 | 0.00% |
Sign in (free) to see its 6 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 13, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.